OCEANIC-AF trial - Hemostasis Today | Hemostasis News, Insights, Stories

Voices Science Insight Innovation

Headlines Hematology Health Medicine VTE ASH Plasma Donation

November, 2026

OCEANIC-AF trial

Factor XIa Inhibition Enters Clinical Practice With First FDA Approval

Nov 12, 2026, 09:35 | Blog

Factor XIa Inhibition Enters Clinical Practice With First FDA Approval

The U.S. Food and Drug Administration (FDA) has approved Sunharbo (asundexian) 50 mg, marking the…

All: 1 Posts: 1 - 100

'

Factor XIa Inhibition Enters Clinical Practice With First FDA Approval

'

Personalizing Hemophilia Care Through Shared Decision-Making - EAHAD

'

When Platelets Cannot Support Thrombin Generation: The Hidden Dimension of Bleeding Disorders

'

PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?

'

Lady Joan Branson's Story - The Hidden Danger of Hospitalization

Nov 12, 2026, 10:00
Akshat Jain: Asundexian for Recurrent Stroke Prevention
Nov 12, 2026, 09:57
Romy Meier: From Research to New Scientific Perspectives on HIT and VITT
Nov 12, 2026, 09:50
Denis Oduor: Did You Know What Happens to Your Body After You Donate Blood?
Nov 12, 2026, 09:49
Care Beyond Borders for Women With Bleeding Disorders – EHC
Nov 12, 2026, 09:30
Roshni Kulkarni: A New Hope for Preventing Recurrent Stroke
Nov 12, 2026, 09:17
Gashaw Arega Mekonnen: Jimma Moments – A Shared Mission for Childhood Cancer Care
Nov 11, 2026, 15:42
Tareq Abadl: The Clinical Impact of Kell Alloimmunization
Nov 11, 2026, 15:30
Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
Nov 11, 2026, 15:25
Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance